טוען...
Characterization of CD22 Expression in Acute Lymphoblastic Leukemia
BACKGROUND: CD22 is a B-lineage differentiation antigen that has emerged as a leading therapeutic target in acute lymphoblastic leukemia (ALL). PROCEDURE: Properties of CD22 expression relevant to therapeutic targeting were characterized in primary samples obtained from children and young adults wit...
שמור ב:
| הוצא לאור ב: | Pediatr Blood Cancer |
|---|---|
| Main Authors: | , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2015
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4405453/ https://ncbi.nlm.nih.gov/pubmed/25728039 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.25410 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|